Sinergium Biotech is leading the new project to develop mRNA vaccines for avian influenza (H5N1)

Daily Current Affairs / Sinergium Biotech is leading the new project to develop mRNA vaccines for avian influenza (H5N1)

Change Language English Hindi

Category : Science and Tech Published on: August 02 2024

Share on facebook

Sinergium Biotech, supported by WHO and MPP, is leading an initiative to develop mRNA vaccines for avian influenza (H5N1), aiming to enhance pandemic preparedness in low- and middle-income
The project will focus on preclinical development and intends to share technology and expertise worldwide, promoting equitable access and fostering international collaboration.

Sinergium Biotech is leading the new project to develop mRNA vaccines for avian influenza (H5N1)